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Background: The initial symptoms of childhood leukaemia and lymphoma are often similar to those of juvenile
idiopathic arthritis (JIA). In our study, we analyzed the frequency and characteristics of musculoskeletal complaints
as the initial presenting symptoms of newly diagnosed leukaemia and lymphoma patients in the past 10 years in
our clinic.
Methods: Using the Hungarian Tumour Register, we performed a retrospective analysis of the medical records of
166 new leukaemia and 95 new lymphoma pediatric patients treated from 1999 to 2009 at the 2nd. Dept. of
Paediatrics of the Semmelweis University in Budapest.
Results: Twenty percent of the leukaemic (33 children) and 2% of the lymphoma patients (2 children) had
musculoskeletal symptoms at first presentation. Two-thirds of both groups of patients had other general symptoms
like fever and/or fatigue. The hip was the most frequently affected joint (7/33) in the leukaemic patients.
Twenty-four percent of all the children had been previously evaluated by an orthopaedist; 12% had visited another
rheumatologist prior to diagnosis. Imaging had been done in an unexpectedly low number of patients prior to
referral to our unit (radiographs: 16 or 48%, ultrasound: 5 patients or 15%). Radiographs of the affected joints were
abnormal in only one case (1/16, 6%). The joint ultrasound was abnormal in only three children of 5 studied
(3/5, 60%). Anaemia (26/32, 6%), thrombocytopenia (78%) and LDH elevation (3–4 times the normal count) were
frequent in the leukaemic patients. Half of the cases had a normal leukocyte count. The lymphoma group had
similar results. Two patients of the leukaemia group received steroid treatment before the final diagnosis. Severe
pain out of proportion to physical findings is another clue.
Conclusions: Haematologic malignancies must be excluded before initiation of therapy for childhood arthritis
among children presenting with musculoskeletal signs and symptoms, particularly in atypical cases. Malignancies
are to be suspected when pain is disproportionately severe compared to the physical examination findings, and
when anaemia, thrombocytopenia, and an elevated LDH level are present. Diagnosing leukaemia early is important
because the use of steroids and immunosuppressive medications may mask and delay its diagnosis. Additionally,
pre-treatment of presumed JIA patients with these drugs who eventually are diagnosed to have a malignancy may
lead to the malignancy being steroid-resistant and more difficult to treat.
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Transient joint and limb pain is common among children,
and in the majority of cases resolves without any treat-
ment. These pains are mostly caused by benign growing
pains or hypermobile joints. It is unusual that these pain
complaints prove to be of organic origin, and even more
unusual that a malignancy is the cause. One percent of
paediatric musculoskeletal complaints are caused by neo-
plasia, most frequently acute lymphoblastic leukaemia
(ALL) [1,2]. Acute lymphoblastic leukaemia is the most
common childhood malignant disease, comprising 25% of
all paediatric malignancies [3].
ALL predominantly affects children between 1 and
5 years of age with a male to female ratio of 1.3:1. The
onset of the disease can be lengthy with a prodromal
stage lasting for weeks, or even months. Initial symp-
toms are often non-specific, such as fever, fatigue, pallor,
or limb and joint pain. Laboratory variables initially are
also often nonspecific; e.g., the white blood cell count is
normal in half the cases of children presenting with
leukaemia [4].
Childhood rheumatic inflammatory diseases, such as
juvenile idiopathic arthritis (JIA), may begin with similar
general symptoms, especially the joint complaints.
Unfortunately, in children with the musculoskeletal
presentation of leukaemia and lymphoma, lab tests and
imaging at first may not detect malignancy, and repeated
testing and prolonged observation and follow-up over
weeks may be needed to diagnose the malignancy [1-4].
After our experiences of diagnosing children with
malignancies in our clinic, we began this study to deter-
mine how prevalent musculoskeletal complaints are in
the Hungarian population of leukaemia and lymphoma
patients.
Methods
By utilizing the national database of the Hungarian
Paediatric Tumour Register, we conducted a retros-
pective institutional study at the 2nd. Dept. of the
Semmelweis University of Budapest of all 166 new
leukaemic and 95 new lymphoma patients treated from
1999 till 2009. All subject’s medical records of children
treated with a haematologic malignancy were analyzed.
The data of the first visit to the haematogist-oncologist
at the time of the diagnosis was reviewed by the
rheumatologist. The data collection and analysis has
been approved by the Institutional Review Board of the
University.
Aims
Our questions were the following: What percent of the
cases diagnosed as hematologic malignancies in our
population start with a rheumatic or musculoskeletal
complaint? Are there similarities or differences regardingthe location of the complaint, pattern, time of the first
presenting symptom, or the laboratory and radiologic
findings compared to that of juvenile idiopathic arthritis?
When do we have to suspect a haematologic malignancy
in a child presenting with musculoskeletal complaints?
Definitions
a) Musculoskeletal/rheumatic complaints: Arthralgia,
arthritis, bone pain, arthromyalgia, inability to walk
b) Arthralgia: joint pain without the objective signs of
inflammation such as swelling, warmth with/or
without restricted range of motion
c) Arthritis: Joint pain with signs of inflammation or
synovitis with or without joint pain.
d) Bone pain: Pain not localized to a joint.
e) Arthromyalgia: bone and muscle pain present at the
same time.
f ) Oligoarthritis: Arthritis affecting less than 5 joints,
g) Polyarthritis: Arthritis affecting 5 or more joints.
h) Lymphadenopathy: A lymph node with a diameter
greater than 1 centimetre.
a. Hepatomegaly: A liver exceeding the rib cage by
more than one finger`s width,
i) Splenomegaly: A spleen exceeding the rib cage by
more than one finger`s width.
j) Anaemia: Haemoglobin concentration under 100 g/l,
k) Thrombocytopenia: A platelet count. under 150 G/l
l) Low-normal platelet count: The range between the
values of 150–250 G/l
m)Leukocytosis: WBC values more than 14.3 G/l,
n) Leukopenia: WBC values fewer than 3.8 G/l.
o) LDH count: LDH values greater than 400 U/l was
considered abnormal
p) CRP: Less than 20 mg/l.
q) Hyperuricaemia: Greater than 420 umol/l.
Note: The laboratory results were collected at the first
presentation of our clinic, at an average of 10 days after
the onset of the first symptoms.
Results
Leukaemia
We analysed the data of the 166 newly diagnosed
leukaemic patients during the above defined period of
time. One hundred and twenty-four (75%) of the children
were male. The median age at the diagnosis was 5.1 years
(range: 1.4-16.4 years). One hundred and sixty-one (97%)
of the children had acute lymphoblastic leukaemia (ALL)
as the final diagnosis and 3% acute myeloid leukaemia
(AML). We found musculoskeletal symptoms as the first
presentation of the disease in 20% of the children with
leukaemia (33/166) and in only 2% (2/95) of the children
with lymphoma. We next did the analysis of this group
Table 2 Joint involvement in pediatric ALL patients
presenting with arthritis and/or arthralgia as the first
complaints
Joint Frequency Percentage
Hip 7/33 21%
Knee 3/33 9%
Spine 3/33 9%
Tarsal 2/33 6%
Lumbal 2/33 6%
Shoulder 1/33 3%
Ankle 1/33 3%
Limbs 1/33 3%
Diffuse pain 4/33 12%
Zombori et al. Pediatric Rheumatology 2013, 11:20 Page 3 of 5
http://www.ped-rheum.com/content/11/1/20focusing on the children with leukaemia or lymphoma
with a musculoskeletal presenting symptom and noting
the location and character of the symptoms.
Two-thirds (22/33) of the leukaemic children with
musculoskeletal symptoms had other symptoms beside
musculoskeletal complaints, most commonly fever, irri-
tability or fatigue. Other associated symptoms and their
frequency are shown in Table 1.
Musculoskeletal or rheumatologic symptoms included
arthromyalgia in about half of the group (54%, 18/33),
followed by arthralgia (36%, 12/33) and arthritis (26%,
8/33). Bone pain was less frequent (12%, 4/33), but
significant as it is not typical for JIA. An limp was
present in 15% (5/33), and another 9% became unable to
walk (3/33). On physical examination, the joints were
less abnormal than expected, and in the presence of
arthritis, inflammatory parameters were also not as high,
and not as abnormal as might be predicted from the
pain severity. Arthralgia and arthritis counted together
were monoarticular in involvement in 45% (15/33), as
well as oligo/pauciarticular involvement in 55% (18/33)
of the cases. Sex and age distribution of children with
arthralgia or arthritis were the following: 79% (26/33)
male, (average age 7.2 years), 21% (7/33) female (average
age 5.1 years). Mono/oligoarticular arthritis was present
in 6 boys and 2 girls. There was no child with poly-
articular arthritis in our study. The hip was the most
frequently affected (7/33) joint, followed by the knee and
the back (Table 2).
In the initial stages of the illness, 76% of the children
with leukaemia who experienced rheumatologic symp-
toms first presented at their family practitioner; 24%
sought an orthopaedist, and 12% a rheumatologist. Final
diagnoses occurred at a clinic or hospital in 85% of the
cases; 9% were made by the family practitioner, and 3.3%
by an orthopaedist or rheumatologist.
Eighty-six percent of the leukaemic children had
anaemia (26/33) and 75% had thrombocytopenia. The
children with thrombocytopenia plus the children withTable 1 Clinical symptoms in ALL pediatric patients
presenting with musculoskeletal complaints
Symptom Frequency Percentage
Fever 10/33 30%
Slight prolonged hyperthermia 3/33 9%
Irritability 8/33 24%
Fatigue 7/33 21%
Paleness 3/33 9%
Abdominal pain 3/33 9%
Swollen face 2/33 6%
Vomiting 2/33 6%
Dizziness 1/33 3%low-normal platelet count totaled 91% of the 33
leukaemic children. For the white blood cell count, half
of the cases had a normal value at the first measure, 39%
had leukocytosis and 9.6% had leucopenia. Ninety-six
percent of the ALL patients had absolute or relative
lymphocytosis. These results are compatible with previous
reports and support that the diagnosis of leukemia often
cannot be initially established based on the peripheral
blood counts alone. Repeat testing of the complete blood
count are needed over the next few days to weeks for
abnormalities to emerge [5-7].
The LDH was elevated in 97% (32/33). A two-fold
increase of the normal level was present in 48% (16/33),
and a three-fold increase in 33% of the cases (11/33).
The CRP exceeded the normal range in 80% of the cases.
The uric acid was normal in most cases as hyper-
uricaemia was seen in only 8%.
Radiological examination abnormalities were rarely
seen at the first presentation of symptoms. A radiograph
of the affected joint or limb was performed in about half
of the cases (16/33); only one was abnormal with osteo-
lytic lesions on the os ischii. Ultrasound was used in 5
cases, (5/33), and 3 showed inflammation of the joint
with the presence of fluid. Three children had a muscu-
loskeletal MRI, but only one was abnormal.
The average time lapse between the onset of symp-
toms and diagnosis of leukemia was 52 days, ranging
from 5 to 721 days. This included two children with very
prolonged periods prior to diagnosis, almost three years
in one, and 9 months in another.
The first diagnosis in these two cases was JIA. It is also
possible, of course, that the child experienced two illnesses,
one after another: first JIA, then a leukaemia, manifesting
itself later. It is more likely that since such a lengthy pro-
drome is not typical for leukaemia, the temporary amelio-
ration of symptoms was the result of the JIA therapy.
Therapy for the children with erroneous JIA diagnoses
were NSAID’s in 12% of the cases while two children
Zombori et al. Pediatric Rheumatology 2013, 11:20 Page 4 of 5
http://www.ped-rheum.com/content/11/1/20(both in the leukaemia group) received steroid therapy
(6%, 2/33). All of the above therapies proved to be
temporarily useful for the alleviation of the pain symp-
toms, and leukaemia was only diagnosed after recurrence
of the chronic pain.
Lymphoma
In the 95 children diagnosed with lymphoma, only 2
cases initially presented with a rheumatologic symptom.
In the first case a 17-year-old boy complained of left
sided hip pain present for 3 months. A hip radiograph
suggested a lytic lesion. A hip MRI described a patho-
logical bone lesion in the affected region. A biopsy was
performed, proving the diagnosis of a lymphoma. The
second case involved a 9-year-old girl who complained of
thigh pain and intermittent fever for 6 months. Her symp-
toms were alleviated by non-steroid anti-inflammatory
drugs (NSAID). An elevated CRP, LDH and ferritin levels
were noted. Bone scintigraphy was performed and
suggested Paget syndrome. MRI described patches of bone
lesions and the resulting biopsy gave the final diagnosis of
lymphoma.
Discussion
Haematological malignancies must be ruled out in chil-
dren with musculoskeletal complaints. This is especially
true if the pain is consistently strong, wakes the child at
night, or localizes to a non-joint area, as these features
are not characteristic for JIA, the most frequent chronic
childhood rheumatologic disease [1]. The frequent, so-
called growing pains, are never accompanied by a labora-
tory or radiological alteration.
What causes the musculoskeletal complaints in a
leukaemia or lymphoma? Infiltration of the synovia, the
periosteum, or the bone marrow by malignant cells is
one explanation, but a secondary uric acid or immune
complex deposits may also cause pain and inflammation
in a joint. A less common factor may be an intraarticular
bleeding resulting from thrombocytopenia [4].
Our results support previous reports that suggest that
pain disproportionate to physical findings, accompanied
by haematologic alterations and pain not permanently
alleviated by NSAIDs, strongly suggest the presence of a
haematologic malignancy [5,8]. But in contrast to other
reports, only 20% of the newly diagnosed ALL patients
had musculoskeletal symptoms, one third of them with
accompanying general complaints. Fever, pallor, bone
pain and night pain are the most likely symptoms of an
underlying leukaemia [9,10]. Severe night-time pains
that awaken a child are not typical for JIA and point
towards malignant diseases [8].
In most of our cases, arthralgias were localised at the
hip joint. Other authors, e.g., Barbosa et al. found that
rheumatologic pain of leukemic origin may also affectthe lower limbs, especially the knee [11]. Other reports
mention wrist, ankle, and elbow involvement as well [8].
In contrast, Trapani et al. found arthritis as the most
frequent presenting symptom, mostly affecting one large
joint in ALL [2]. Arthralgia was less frequent in their
study, localising mostly at the shoulders, arms, spine and
knee. Arthritis was almost never accompanied by morn-
ing joint stiffness. Stiffness of the joints is an important
symptom suggesting JIA over a malignancy. Interes-
tingly, 79% of leukaemia patients in our series presenting
with mono/oligo arthritis or arthralgia were boys. Thus
in younger male children with oligoarticular disease the
possibility of leukemia should also be entertained, espe-
cially because the 2/3 of oligoarticular JIA patients are
girls. Lymphadenopathy and hepatosplenomegaly can be
present in both ALL and JIA, so we don’t regard it as a
good differential diagnostic feature.
Regarding the laboratory testing, we would like to
emphasize the presence of thrombocytopenia in the
leukemic patients and point out that juvenile idiopathic
arthritis presents more often with thrombocytosis, which
results from the stimulation of megakaryocytes by IL-6 as
part of the acute phase reaction [12]. Barbosa et al.
emphasize the importance of the elevated LDH level [11],
with the neoplasia group having a 2.2 times the normal
range elevation, while the JIA group only a 0.8 times
normal. Our study found that LDH in the neoplasia group
was usually 3–4 times above the normal range. Another
report suggested that the LDH was also a good marker for
therapy and prognosis and of a malignant disease [2].
Most of the patients were anaemic in an Indian publi-
cation similar to our findings, although anaemia in itself
is not always that typical for leukaemia [6,10]. The white
blood cell count can be normal, elevated of decreased at
the beginning of the ALL, but absolute or relative lym-
phocytosis is very characteristic to ALL.
ANA positivity is common in the oligoarticular,
psoriasis-associated and polyarticular JIA, but it doesn’t
exclude the presence of haematologic malignancies.
Strong ANA positivity has been found in 17% of children
with ALL and 5% of children with diverse lymphopro-
liferative diseases [6,13].
The importance of x-rays in early detection of leukae-
mia has been emphasized by several authors. Emphasis
is placed on boney signs present in some children with
leukaemia, such as osteoporosis, raindrop-like lytic
lesions, radiolucent metaphyseal bands on long bones,
and wedge fractures of vertebrae [7]. Radiological signs
of ALL are seen in 45-70% of children at presentation,
although these lesions may not be easy to detect [14].
This high rate was not typical of our study group. We
would like to note, however, that an x-rays was performed
in a far fewer number of our cases than performed in
some other reports in the literature.
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whose disease begins with rheumatologic symptoms have
a better 5-year survival rate then non-rheumatologic ALL
patients. In this rheumatologic symptom group, an even-
tual relapse also usually starts with these musculoskeletal
symptoms. Thus this group may be categorized as a sub-
group of ALL in the future [10].
Two of the children received steroid treatment when the
initial suspected diagnosis of JIA was made. The danger of
steroid treatment is that it may mask the symptoms, signs,
and abnormal laboratory tests of leukaemia; the correct
diagnosis and immuncytologic typing might be delayed
and disturbed. Finally, it may may lead to reclassification
of the disease to a higher risk group, according to the IC
BFM 2002 protocol for ALL used in our institute [15,16].
While survival in the low risk group is 80-90%, that of the
high risk group is only 60%, resulting not only from the
stage or progression of the leukaemia, but also from side
effects of the more aggressive treatment.
Conclusions
Awareness of the possibility of a haematologic malig-
nancy, such as leukaemia, in a child presenting with
musculoskeletal complaints is essential. This is especially
important when the signs and complaints are not typical
of the paediatric rheumatologic and musculoskeletal
diseases and syndromes, e.g. juvenile idiopathic arthritis,
growing pains and hypermobile joints. The most
frequent signs of malignancies presenting with a muscu-
loskeletal presentation are migratory bone and joint pain
with variable intensity and limping without significant
physical findings. These children often are febrile and
have elevated inflammatory laboratory markers such as
the ESR and CRP. In our patients, we found the following
signs useful to suggest a haematologic malignancy in
children experiencing musculoskeletal and rheumatologic
symptoms: pain disproportionate to the physical findings,
lack of morning stiffness typical of arthritis, lymphadeno-
pathy, hepatosplenomegaly, thrombocytopenia, anaemia,
and a LDH 2–5 times the normal range of LDH.
If malignancy is strongly suspected, a definitive diagnosis
should be made by a bone marrow biopsy, as blasts are
often not present on the peripheral smear of the CBC. Ma-
lignancy should be eliminated as a possibility before the
introduction of steroid or immunosuppressive therapy for
an arthritis disease.
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